A&R:2021 年美国风湿病学会青少年特发性关节炎治疗指南:非药物治疗、药物监测、免疫接种和影像学建议

2022-04-19 MedSci原创 MedSci原创

本指南中的建议包括使用物理治疗和职业治疗干预;健康、均衡、适合年龄的饮食;药物的特定实验室监测;广泛使用免疫接种;并与患者/护理人员共享决策。

    目的:为青少年特发性关节炎(JIA)的管理提供建议,无论JIA表型如何,重点关注非药物治疗、药物监测、免疫接种和影像学

    方法:研究人员制定了临床相关的患者/人群、干预、比较和结果问题。在进行系统的文献回顾后,使用推荐分级评估、制定和评估方法对证据质量进行评级(高、中、低或非常低)。包括临床医生和患者/护理人员在内的投票小组就建议的方向(支持或反对)和强度(强烈或有条件的)达成共识。

    结果:本指南中的建议包括使用物理治疗和职业治疗干预;健康、均衡、适合年龄的饮食;药物的特定实验室监测;广泛使用免疫接种;并与患者/护理人员共享决策。所有JIA患者的疾病管理都涉及非药物治疗、药物监测、免疫接种和影像学检查。所有建议的证据质量被评为低或非常低。因此,超过一半的建议是有条件的。

   结论:该临床实践指南是对2019年美国风湿病学会JIA和葡萄膜炎指南的补充,2019年版指南涉及多关节炎、骶髂关节炎、附着点炎和葡萄膜炎。该临床实践指南也是2021年关于少关节炎、颞下颌关节炎和全身性JIA的并发指南。它是作为临床医生、患者和护理人员进行决策的工具。该指南中的建议考虑了关节和非关节临床表现的严重程度以及患者的生活质量。尽管证据质量普遍较低且许多建议是有条件的,但将护理人员和患者纳入决策过程可增强指南的相关性和适用性。重要的是要记住这些都是建议。与往常一样,临床决定应由临床医生和患者/护理人员做出

 

出处:Onel, K.B., Horton, D.B., Lovell, D.J., et al. (2022), 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. Arthritis Rheumatol, 74: 570-585. https://doi.org/10.1002/art.42036

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1934938, encodeId=4bcb193493832, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Thu Jun 23 15:22:14 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1894849, encodeId=c6ed1894849d5, content=<a href='/topic/show?id=e45b6e859f3' target=_blank style='color:#2F92EE;'>#特发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67859, encryptionId=e45b6e859f3, topicName=特发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sun Jun 26 00:22:14 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807442, encodeId=6aa3180e442fc, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jun 15 22:22:14 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214413, encodeId=03ae12144138e, content=认真***, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b6e2403217, createdName=1235bd28m70暂无昵称, createdTime=Tue Apr 26 10:08:37 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212786, encodeId=ddd61212e86d1, content=***!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387b1515299, createdName=jhn2013, createdTime=Wed Apr 20 10:25:40 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266442, encodeId=525c126644252, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Apr 19 21:22:14 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581707, encodeId=ae901581e0723, content=<a href='/topic/show?id=e61f29043a0' target=_blank style='color:#2F92EE;'>#免疫接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29043, encryptionId=e61f29043a0, topicName=免疫接种)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69e416863955, createdName=12498ca5m88暂无昵称, createdTime=Tue Apr 19 21:22:14 CST 2022, time=2022-04-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1934938, encodeId=4bcb193493832, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Thu Jun 23 15:22:14 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1894849, encodeId=c6ed1894849d5, content=<a href='/topic/show?id=e45b6e859f3' target=_blank style='color:#2F92EE;'>#特发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67859, encryptionId=e45b6e859f3, topicName=特发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sun Jun 26 00:22:14 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807442, encodeId=6aa3180e442fc, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jun 15 22:22:14 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214413, encodeId=03ae12144138e, content=认真***, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b6e2403217, createdName=1235bd28m70暂无昵称, createdTime=Tue Apr 26 10:08:37 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212786, encodeId=ddd61212e86d1, content=***!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387b1515299, createdName=jhn2013, createdTime=Wed Apr 20 10:25:40 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266442, encodeId=525c126644252, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Apr 19 21:22:14 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581707, encodeId=ae901581e0723, content=<a href='/topic/show?id=e61f29043a0' target=_blank style='color:#2F92EE;'>#免疫接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29043, encryptionId=e61f29043a0, topicName=免疫接种)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69e416863955, createdName=12498ca5m88暂无昵称, createdTime=Tue Apr 19 21:22:14 CST 2022, time=2022-04-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1934938, encodeId=4bcb193493832, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Thu Jun 23 15:22:14 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1894849, encodeId=c6ed1894849d5, content=<a href='/topic/show?id=e45b6e859f3' target=_blank style='color:#2F92EE;'>#特发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67859, encryptionId=e45b6e859f3, topicName=特发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sun Jun 26 00:22:14 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807442, encodeId=6aa3180e442fc, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jun 15 22:22:14 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214413, encodeId=03ae12144138e, content=认真***, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b6e2403217, createdName=1235bd28m70暂无昵称, createdTime=Tue Apr 26 10:08:37 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212786, encodeId=ddd61212e86d1, content=***!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387b1515299, createdName=jhn2013, createdTime=Wed Apr 20 10:25:40 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266442, encodeId=525c126644252, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Apr 19 21:22:14 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581707, encodeId=ae901581e0723, content=<a href='/topic/show?id=e61f29043a0' target=_blank style='color:#2F92EE;'>#免疫接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29043, encryptionId=e61f29043a0, topicName=免疫接种)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69e416863955, createdName=12498ca5m88暂无昵称, createdTime=Tue Apr 19 21:22:14 CST 2022, time=2022-04-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1934938, encodeId=4bcb193493832, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Thu Jun 23 15:22:14 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1894849, encodeId=c6ed1894849d5, content=<a href='/topic/show?id=e45b6e859f3' target=_blank style='color:#2F92EE;'>#特发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67859, encryptionId=e45b6e859f3, topicName=特发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sun Jun 26 00:22:14 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807442, encodeId=6aa3180e442fc, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jun 15 22:22:14 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214413, encodeId=03ae12144138e, content=认真***, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b6e2403217, createdName=1235bd28m70暂无昵称, createdTime=Tue Apr 26 10:08:37 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212786, encodeId=ddd61212e86d1, content=***!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387b1515299, createdName=jhn2013, createdTime=Wed Apr 20 10:25:40 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266442, encodeId=525c126644252, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Apr 19 21:22:14 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581707, encodeId=ae901581e0723, content=<a href='/topic/show?id=e61f29043a0' target=_blank style='color:#2F92EE;'>#免疫接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29043, encryptionId=e61f29043a0, topicName=免疫接种)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69e416863955, createdName=12498ca5m88暂无昵称, createdTime=Tue Apr 19 21:22:14 CST 2022, time=2022-04-19, status=1, ipAttribution=)]
    2022-04-26 1235bd28m70暂无昵称

    认真***

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1934938, encodeId=4bcb193493832, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Thu Jun 23 15:22:14 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1894849, encodeId=c6ed1894849d5, content=<a href='/topic/show?id=e45b6e859f3' target=_blank style='color:#2F92EE;'>#特发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67859, encryptionId=e45b6e859f3, topicName=特发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sun Jun 26 00:22:14 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807442, encodeId=6aa3180e442fc, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jun 15 22:22:14 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214413, encodeId=03ae12144138e, content=认真***, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b6e2403217, createdName=1235bd28m70暂无昵称, createdTime=Tue Apr 26 10:08:37 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212786, encodeId=ddd61212e86d1, content=***!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387b1515299, createdName=jhn2013, createdTime=Wed Apr 20 10:25:40 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266442, encodeId=525c126644252, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Apr 19 21:22:14 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581707, encodeId=ae901581e0723, content=<a href='/topic/show?id=e61f29043a0' target=_blank style='color:#2F92EE;'>#免疫接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29043, encryptionId=e61f29043a0, topicName=免疫接种)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69e416863955, createdName=12498ca5m88暂无昵称, createdTime=Tue Apr 19 21:22:14 CST 2022, time=2022-04-19, status=1, ipAttribution=)]
    2022-04-20 jhn2013

    ***!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1934938, encodeId=4bcb193493832, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Thu Jun 23 15:22:14 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1894849, encodeId=c6ed1894849d5, content=<a href='/topic/show?id=e45b6e859f3' target=_blank style='color:#2F92EE;'>#特发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67859, encryptionId=e45b6e859f3, topicName=特发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sun Jun 26 00:22:14 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807442, encodeId=6aa3180e442fc, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jun 15 22:22:14 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214413, encodeId=03ae12144138e, content=认真***, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b6e2403217, createdName=1235bd28m70暂无昵称, createdTime=Tue Apr 26 10:08:37 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212786, encodeId=ddd61212e86d1, content=***!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387b1515299, createdName=jhn2013, createdTime=Wed Apr 20 10:25:40 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266442, encodeId=525c126644252, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Apr 19 21:22:14 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581707, encodeId=ae901581e0723, content=<a href='/topic/show?id=e61f29043a0' target=_blank style='color:#2F92EE;'>#免疫接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29043, encryptionId=e61f29043a0, topicName=免疫接种)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69e416863955, createdName=12498ca5m88暂无昵称, createdTime=Tue Apr 19 21:22:14 CST 2022, time=2022-04-19, status=1, ipAttribution=)]
    2022-04-19 lmm397
  7. [GetPortalCommentsPageByObjectIdResponse(id=1934938, encodeId=4bcb193493832, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Thu Jun 23 15:22:14 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1894849, encodeId=c6ed1894849d5, content=<a href='/topic/show?id=e45b6e859f3' target=_blank style='color:#2F92EE;'>#特发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67859, encryptionId=e45b6e859f3, topicName=特发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sun Jun 26 00:22:14 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807442, encodeId=6aa3180e442fc, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jun 15 22:22:14 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214413, encodeId=03ae12144138e, content=认真***, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b6e2403217, createdName=1235bd28m70暂无昵称, createdTime=Tue Apr 26 10:08:37 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212786, encodeId=ddd61212e86d1, content=***!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387b1515299, createdName=jhn2013, createdTime=Wed Apr 20 10:25:40 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266442, encodeId=525c126644252, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Apr 19 21:22:14 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581707, encodeId=ae901581e0723, content=<a href='/topic/show?id=e61f29043a0' target=_blank style='color:#2F92EE;'>#免疫接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29043, encryptionId=e61f29043a0, topicName=免疫接种)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69e416863955, createdName=12498ca5m88暂无昵称, createdTime=Tue Apr 19 21:22:14 CST 2022, time=2022-04-19, status=1, ipAttribution=)]

相关资讯

ACR:美国青少年特发性关节炎(JIA)治疗建议更新

青少年特发性关节炎   近日,美国风湿病学会(ACR)在《关节炎治疗与研究》杂志4月期上发布了针对青少年特发性关节炎(JIA)的治疗建议。   该建议的关注点为:① JIA是一种异质性疾病,强调根据疾病的不同临床表现开始不同的治疗方案。② 将JIA分为5类,即有受累关节≤4个的关节炎病史;有受累关节≥5个的关节炎病史;活动性骶髂关节炎;有活动性全身症状但无活动性关节炎的全身型;有活动性关节炎但

卡那奴单抗可治疗青少年特发性关节

     欧美的一项研究表明,卡那奴单抗有效治疗伴发热的活动性青少年全身特发性关节炎(sJIA)。研究证实,卡那奴单抗疗效优于安慰剂,可成功减少类固醇用量,显著降低sJIA复发风险,安全性可接受。   青少年全身特发性关节炎(sJIA) 是由白介素-1β介导的自身炎症性疾病。卡那奴单抗是一种选择性人抗白介素-1β单克隆抗体。本研究通过二个重要的Ⅲ期试验来评价卡那奴单抗的疗

Ann Rheum Dis :换用生物制剂治疗JIA疗效更小

   来自荷兰的一项研究表明,换用另一种生物制剂很常见,尤其是对于全身性青少年特发性关节炎(JIA)患者。第二个(和第三个)生物制剂比首个药物疗效更小。医师选择第二个生物制剂主要取决于(药物)利用率和JIA类型。该论文发表在2013年第5期《风湿病学年鉴》[Ann Rheum Dis 2013;72:721-727]。  儿童关节炎和生物制剂登记(ABC登记)目的是包括所有使用过生物制剂的荷兰JI

强生向美国FDA提交两份申请,申请批准golimumab治疗少年特发性关节炎和银屑病关节炎

强生制药公司近日宣布,已向美国食品药品监督管理局(FDA)提交两份补充生物制品许可申请(sBLA),以寻求批准SIMPONIARIA。

美国青少年特发性关节炎(JIA)治疗建议更新( 附下载)

作者:北京医院陈颖娟 刘爱华 黄慈波 来源:中国医学论坛报 青少年特发性关节炎   近日,美国风湿病学会(ACR)在《关节炎治疗与研究》杂志4月期[Arthritis Care Res 2011,63(4):465]上发布了针对青少年特发性关节炎(JIA)的治疗建议。   该建议的关注点为:① JIA是一种异质性疾病,强调根据疾病的不同临床表现开始